Tetherex Pharmaceuticals focuses on the development of novel selectin inhibitor products to treat thrombosis, inflammatory diseases and cancer.
Business Model:
Revenue: $7.3M
Employees: 11-50
Address: 840 Research Parkway
City: Oklahoma City
State: OK
Zip: 73104
Country: US
Tetherex Pharmaceuticals focuses on the development of novel selectin inhibitor products to treat thrombosis, inflammatory diseases and cancer.
Contact Phone:
+14052711469
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2014 | Seed Round | 1 | - |
i2E i2E |
4/2018 | Series B | 2 | $50M |
MPM Capital Phil Jones MPM Capital Phil Jones |
2/2015 | Seed Round | $1.3M | 5/2015 | Debt | $4M | 2/2015 | Equity | $1.3M | 6/2015 | Debt Financing | $2M | 1/2014 | Seed Round | 1 | - |
i2E i2E |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|